Athanase Innovation AB (OSTO:ATIN) 3-1 Month Momentum %: 15.73% (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr20.20
View Full Analysis

What is Athanase Innovation AB 3-1 Month Momentum %?

Athanase Innovation AB OSTO:ATIN 26 3-1 Month Momentum % is 15.73% as of Sep. 21, 2026. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), Athanase Innovation AB's 3-1 Month Momentum % is 15.73%.

The industry rank for Athanase Innovation AB's 3-1 Month Momentum % or its related term are showing as below:

OSTO:ATIN's 3-1 Month Momentum % is not ranked
in the Asset Management industry.
Industry Median: -0.22 vs OSTO:ATIN: 15.73

Athanase Innovation AB  (OSTO:ATIN) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Athanase Innovation AB 3-1 Month Momentum % Related Terms


OSTO:ATIN vs EVG, SMM, NHS: 3-1 Month Momentum % Comparison

For the Asset Management subindustry, Athanase Innovation AB's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Athanase Innovation AB 3-1 Month Momentum % vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's 3-1 Month Momentum % falls into.


OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB  (OSTO:ATIN) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of 15.73% mean?
Athanase Innovation AB (OSTO:ATIN) has a 3-1 Month Momentum % of 15.73% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's 3-1 Month Momentum % too high?
Athanase Innovation AB's current 3-1 Month Momentum % is 15.73%. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's 3-1 Month Momentum % compare to EVG and SMM?
Athanase Innovation AB's 3-1 Month Momentum % of 15.73% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for an Asset Management company?
A good 3-1 Month Momentum % depends on the Asset Management industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Athanase Innovation AB and its competitors. Athanase Innovation AB's current 3-1 Month Momentum % is 15.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current 3-1 Month Momentum % of 15.73%. The current 3-1 Month Momentum % is 15.73%. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current 3-1 Month Momentum % is 15.73% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.20
Price